Industry Reports

Published on: 09/03/2020
While COVID-19 has severely hampered sales for medical device original equipment manufacturers (OEMs), the resumption of elective surgeries has begun to restore demand for devices and instruments.  Merger and acquisition activity in the Medical Device Outsourcing industry has stalled through the first half of 2020, with 19 transactions announced or completed year-to-date (YTD) compared to 46 deals in YTD 2019.
Published on: 08/13/2020
The pandemic has emphasized the need for the industry to rethink its reliance on offshore manufacturing and complex global supply chains, as well as how to utilize technology to adopt a more decentralized approach to conducting clinical trials.  While COVID-19 has certainly challenged contract research organizations (CROs) in administration of on-site activities and clinical trials, it has also fostered heightened innovation and implementation of remote technology.  Virtual trials and eClinical solutions have gained increased adoption as CROs seek creative options for decentralized management of clinical trials.
Published on: 07/15/2020
Merger and acquisition (M&A) activity has slowed substantially in year-to-date (YTD) 2020 with seven transactions announced or completed compared to 25 transactions in YTD 2019.  However, as Q2 closes, the substantial amount of private equity dry powder presents a favorable backdrop for deal activity to rebound in the Healthcare Staffing industry.
Published on: 04/06/2020
The current pandemic has necessitated additional healthcare professionals, resulting in unprecedented surges of demand as healthcare organizations face an influx of new patients.  In addition, regular healthcare staff have been directly impacted by the coronavirus, with implications including overtime, sick family members, and school closures.
Published on: 03/18/2020
Our newly released Q1 Behavioral Healthcare Services report discusses current industry dynamics as well as merger and acquisition (M&A) trends and activity through March 2020.  Amid instability caused by the fast-spreading coronavirus and subsequent dips in the financial markets, the Behavioral Healthcare Services industry stands out as a recession-resilient sector and a safe haven for M&A opportunities and investors.
Published on: 02/24/2020
Rising demand for digital health applications promoting patient engagement and interoperability among medical platforms has driven demand in the Healthcare Information Technology (HCIT) industry.
Published on: 01/09/2020
Demand in the Medical Device Outsourcing industry has been fueled by a period with remarkable innovation and adoption of new medical technologies as well as the noticeable graying of the U.S. population and corresponding increase in chronic disease and healthcare utilization.  
Published on: 01/09/2020
Robust consolidation activity among outsourced pharmaceutical providers, particularly Contract Development and Manufacturing Organizations (CDMOs) and Contract Research Organizations (CROs), has been driven by pharmaceutical companies seeking to reduce costs and obtain expertise and talent associated with all phases of drug development and production.  
Published on: 11/19/2019
We are witnessing an unprecedented level of merger and acquisition (M&A) activity and once-in-a-generation valuations for quality providers of autism and childhood behavioral health services.
Published on: 10/17/2019
The fundamentals in the Pharmaceutical Outsourcing industry remain solid as the sector continues to benefit from a record number of drugs under development and a rise in research and development initiatives targeting rare diseases.

Pages